ARCHIVES

Appropriators Ask What Happens After NIH Budget-Doubling Ends In FY2004.

This article is from The Cancer Letter archive.

Vol. 27 No. 21 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

October 10, 1997

Bypass Budget For FY 1992 Shown In Chart

May 18, 1990

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

Medline Plus Provides Info To Patients About Prescriptions

May 28, 2004